BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 948 | Download: 891
Publication Name World Journal of Clinical Oncology
Manuscript ID 8731
Country France
Received
2014-01-04 13:33
Peer-Review Started
2014-01-04 19:10
To Make the First Decision
2014-02-13 16:09
Return for Revision
2014-02-19 22:55
Revised
2014-03-18 17:54
Second Decision
2014-06-27 17:36
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-27 17:49
Articles in Press
2014-06-27 18:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-21 16:16
Publish the Manuscript Online
2014-08-01 15:17
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Epithelial-mesenchymal transition transcription factors and miRNAs: “Plastic surgeons” of breast cancer
Manuscript Source Invited Manuscript
All Author List Caroline Moyret-Lalle, Emmanuelle Ruiz and Alain Puisieux
Funding Agency and Grant Number
Funding Agency Grant Number
Ligue Nationale contre le Cancer to Puisieux A
Corresponding Author Caroline Moyret-Lalle, PhD, Laboratoire d’EXcellence DEVweCAN, INSERM UMR-S1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 43 Boulevard du 11 Novembre 1918, 69008 Lyon, France. caroline.moyret-lalle@lyon.unicancer.fr
Key Words Embryonic transcription factors; Epithelial to mesenchymal transition; Breast cancer; MicroRNAs; Dicer; Feedback loop
Core Tip Epithelial-mesenchymal transition (EMT) and the reverse mesenchymal-epithelial transition (MET) are both involved in breast cancer plasticity. Embryonic transcription factors and miRNAs are key players regulating the balance between these two processes allowing cells that underwent EMT to transiently re-acquire epithelial phenotype. Here we highlighted the complex transcription factors/miRNAs regulation networks involved in EMT-MET during breast cancer progression and the central role played by Dicer, the key enzyme of miRNAs processing, in EMT process. These key regulators of EMT-MET may represent predictive markers and potential therapeutic targets for breast cancers.
Publish Date 2014-08-01 15:17
Citation Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: “Plastic surgeons” of breast cancer. World J Clin Oncol 2014; 5(3): 311-322
URL http://www.wjgnet.com/2218-4333/full/v5/i3/311.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i3.311
Full Article (PDF) WJCO-5-311.pdf
Full Article (Word) WJCO-5-311.doc
Manuscript File 8731-Review.docx
Answering Reviewers 8731-Answering reviewers.pdf
Copyright License Agreement 8731-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 8731-Language certificate.pdf
Peer-review Report 8731-Peer review(s).pdf
Scientific Misconduct Check 8731-CrossCheck.jpg
Scientific Editor Work List 8731-Scientific editor work list.pdf